Our Mission
Amprion revolutionizes diagnosis for brain diseases. Through molecular testing, we accelerate medical science for personalized medicine.
Our Story
As a pioneer in Prion Detection Science™️, we believe precision medicine is the new frontier. Through our work, we strive to positively impact brain disease diagnosis and treatment as the world population ages rapidly. See our evolving scientific journey below.
Once Upon A Time
The Pivot
As mad cow disease dissipates, the team pivots, asking: Is there a parallel between misfolded proteins in mad cow disease and human brain disorders?
Aha Moment!
Dr. Soto proves there is a similarity and develops an assay to detect misfolded Abeta, a biomarker found in most Alzheimer’s patients.
Amprion Was Born
The team expands research to detect other misfolded proteins, including Synuclein and Tau.
Our Mission
Revolutionize molecular testing to help doctors diagnose brain diseases accurately.
Our Science
Amprion expands its lab, conducting further scientific research using its proprietary Prion Detection Science™️.
Scientists At Work
The company establishes a state-of-the-art clinical lab run by dedicated scientists and experts, not to mention tireless bots when humans are off the clock.
FDA Breakthrough Designation
The US FDA awards Amprion Breakthrough Device Designation for detecting misfolded Synuclein, a key brain disease biomarker.
Covid Push For CLIA
Team Amprion, standing 6-feet apart, worked through Covid and reached a significant milestone. We achieved CLIA approval for our clinical lab.
SYNTap Test Commercial Rollout
Our first biomarker test is here! This breakthrough test helps doctors diagnose Parkinson’s, Lewy Body Dementia by detecting misfolded Synuclein in CSF.
